华法林通过ERK1/2和β-catenin信号通路诱导主动脉瓣钙化
本研究探讨华法林对主动脉瓣间质细胞(AVIC)成骨蛋白表达的影响及信号通路。从正常主动脉瓣和主动脉瓣狭窄患者分离人AVIC,华法林(而非肝素或达比加群)显著增加Runx-2和Osx表达,该效应由ERK1/2介导,在病变AVIC中β-catenin信号也参与。结果提示华法林在主动脉瓣钙化中的作用及华法林诱导主动脉瓣狭窄的潜在机制。
要点
- 华法林增加正常和病变AVIC的Runx-2和Osx表达,肝素和达比加群无此效应。
- ERK1/2抑制减弱华法林诱导的Runx-2表达,在正常和病变AVIC中均如此。
- 病变AVIC中β-catenin信号也参与华法林诱导的成骨活动。
核心结论
- 华法林诱导正常和病变人AVIC的成骨活性,ERK1/2在两者中均介导该效应,病变AVIC中β-catenin信号也起作用。
研究设计与样本
- 实验研究,从心脏移植患者正常主动脉瓣和主动脉瓣狭窄行主动脉瓣置换患者病变瓣膜分离人AVIC,用不同抗凝药处理,免疫印迹评估成骨蛋白表达及信号通路磷酸化。
主要发现
- 华法林(而非肝素或达比加群)显著增加正常和病变人AVIC中Runx-2和Osx表达。
- 华法林处理后病变AVIC中β-catenin蛋白表达上调及核转位,正常AVIC无此变化。
- 华法林仅诱导病变AVIC中LRP6磷酸化,诱导正常和病变AVIC中ERK1/2磷酸化。
- LRP6抑制减弱病变AVIC中华法林诱导的Runx-2表达,ERK1/2抑制减弱正常和病变AVIC中的Runx-2表达。
临床怎么用
- 提示华法林可能通过ERK1/2和β-catenin信号促进主动脉瓣钙化,为华法林相关主动脉瓣狭窄的机制提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent clinical evidence suggests an association between warfarin use and calcification of the aortic valve. We sought to determine the effect of warfarin on aortic valve interstitial cell (AVIC) osteogenic protein expression and the signaling pathways by which this effect is mediated. METHODS: Human AVICs were isolated from normal aortic valves of patients undergoing cardiac transplantation, whereas diseased AVICs were isolated from patients undergoing aortic valve replacement for aortic stenosis. AVICs were treated with various anticoagulants, and osteogenic protein expression was evaluated using immunoblotting. Phosphorylation of lipoprotein receptor-related protein 6 (LRP6) and extracellular signal-regulated kinase 1/2 (ERK1/2) was evaluated after treatment with warfarin. AVICs were pretreated with LRP6 inhibitor dkk1 and ERK1/2 inhibitor PD98059 followed by treatment with warfarin, and osteogenic protein expression was evaluated. RESULTS: Warfarin, but not heparin or dabigatran, significantly increased Runx-2 and Osx expression in both normal and diseased human AVICs. Upregulation of β-catenin protein expression and nuclear translocation occurred in diseased AVICs but not normal AVICs after warfarin treatment. Warfarin induced phosphorylation of LRP6 in diseased AVICs only and phosphorylation of ERK1/2 in both normal and diseased AVICs. LRP6 inhibition attenuated warfarin-induced Runx-2 expression in diseased AVICs. ERK1/2 inhibition attenuated warfarin-induced Runx-2 expression in both normal and diseased AVICs. CONCLUSIONS: Warfarin induces osteogenic activity in normal and diseased isolated human AVICs. This effect is mediated by ERK1/2 in both diseased and normal AVICs, but in diseased AVICs β-catenin signaling also plays a role. These results implicate the role of warfarin in aortic valve calcification and highlight potential mechanisms for warfarin-induced aortic stenosis.
引用
- Venardos N, Gergen AK, Jarrett M, et al. Warfarin Induces Calcification of the Aortic Valve Through Extracellular Signal-regulated Kinase 1/2 and β-catenin Signaling. Ann Thorac Surg. 2021. PMID: 33901456. doi:10.1016/j.athoracsur.2021.03.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。